|
US9006487B2
(en)
|
2005-06-15 |
2015-04-14 |
Massachusetts Institute Of Technology |
Amine-containing lipids and uses thereof
|
|
JP2017061563A
(ja)
*
|
2008-11-07 |
2017-03-30 |
マサチューセッツ インスティテュート オブ テクノロジー |
アミノアルコールリピドイドおよびその使用
|
|
US10844028B2
(en)
|
2008-11-07 |
2020-11-24 |
Massachusetts Institute Of Technology |
Aminoalcohol lipidoids and uses thereof
|
|
JP2012508235A
(ja)
*
|
2008-11-07 |
2012-04-05 |
マサチューセッツ インスティテュート オブ テクノロジー |
アミノアルコールリピドイドおよびその使用
|
|
US11414393B2
(en)
|
2008-11-07 |
2022-08-16 |
Massachusetts Institute Of Technology |
Aminoalcohol lipidoids and uses thereof
|
|
US10189802B2
(en)
|
2008-11-07 |
2019-01-29 |
Massachusetts Institute Of Technology |
Aminoalcohol lipidoids and uses thereof
|
|
US9556110B2
(en)
|
2008-11-07 |
2017-01-31 |
Massachusetts Institute Of Technology |
Aminoalcohol lipidoids and uses thereof
|
|
US10576166B2
(en)
|
2009-12-01 |
2020-03-03 |
Translate Bio, Inc. |
Liver specific delivery of messenger RNA
|
|
US9238716B2
(en)
|
2011-03-28 |
2016-01-19 |
Massachusetts Institute Of Technology |
Conjugated lipomers and uses thereof
|
|
US10117934B2
(en)
|
2011-03-28 |
2018-11-06 |
Massachusetts Institute Of Technology |
Conjugated lipomers and uses thereof
|
|
US10933139B2
(en)
|
2011-03-28 |
2021-03-02 |
Massachusetts Institute Of Technology |
Conjugated lipomers and uses thereof
|
|
US9597413B2
(en)
|
2011-06-08 |
2017-03-21 |
Shire Human Genetic Therapies, Inc. |
Pulmonary delivery of mRNA
|
|
US11185595B2
(en)
|
2011-06-08 |
2021-11-30 |
Translate Bio, Inc. |
Lipid nanoparticle compositions and methods for mRNA delivery
|
|
US10888626B2
(en)
|
2011-06-08 |
2021-01-12 |
Translate Bio, Inc. |
Lipid nanoparticle compositions and methods for mRNA delivery
|
|
US11951180B2
(en)
|
2011-06-08 |
2024-04-09 |
Translate Bio, Inc. |
Lipid nanoparticle compositions and methods for MRNA delivery
|
|
US11052159B2
(en)
|
2011-06-08 |
2021-07-06 |
Translate Bio, Inc. |
Lipid nanoparticle compositions and methods for mRNA delivery
|
|
US9308281B2
(en)
|
2011-06-08 |
2016-04-12 |
Shire Human Genetic Therapies, Inc. |
MRNA therapy for Fabry disease
|
|
US11730825B2
(en)
|
2011-06-08 |
2023-08-22 |
Translate Bio, Inc. |
Lipid nanoparticle compositions and methods for mRNA delivery
|
|
US10507249B2
(en)
|
2011-06-08 |
2019-12-17 |
Translate Bio, Inc. |
Lipid nanoparticle compositions and methods for mRNA delivery
|
|
US11951179B2
(en)
|
2011-06-08 |
2024-04-09 |
Translate Bio, Inc. |
Lipid nanoparticle compositions and methods for MRNA delivery
|
|
US11951181B2
(en)
|
2011-06-08 |
2024-04-09 |
Translate Bio, Inc. |
Lipid nanoparticle compositions and methods for mRNA delivery
|
|
US11547764B2
(en)
|
2011-06-08 |
2023-01-10 |
Translate Bio, Inc. |
Lipid nanoparticle compositions and methods for MRNA delivery
|
|
US10413618B2
(en)
|
2011-06-08 |
2019-09-17 |
Translate Bio, Inc. |
Lipid nanoparticle compositions and methods for mRNA delivery
|
|
US10350303B1
(en)
|
2011-06-08 |
2019-07-16 |
Translate Bio, Inc. |
Lipid nanoparticle compositions and methods for mRNA delivery
|
|
US11291734B2
(en)
|
2011-06-08 |
2022-04-05 |
Translate Bio, Inc. |
Lipid nanoparticle compositions and methods for mRNA delivery
|
|
US11338044B2
(en)
|
2011-06-08 |
2022-05-24 |
Translate Bio, Inc. |
Lipid nanoparticle compositions and methods for mRNA delivery
|
|
US10238754B2
(en)
|
2011-06-08 |
2019-03-26 |
Translate Bio, Inc. |
Lipid nanoparticle compositions and methods for MRNA delivery
|
|
US10086013B2
(en)
|
2011-10-27 |
2018-10-02 |
Massachusetts Institute Of Technology |
Amino acid-, peptide- and polypeptide-lipids, isomers, compositions, and uses thereof
|
|
US9512073B2
(en)
|
2011-10-27 |
2016-12-06 |
Massachusetts Institute Of Technology |
Amino acid-, peptide-and polypeptide-lipids, isomers, compositions, and uses thereof
|
|
US10682374B2
(en)
|
2011-10-27 |
2020-06-16 |
Massachusetts Intstitute Of Technology |
Amino acid-, peptide- and polypeptide-lipids, isomers, compositions, and uses thereof
|
|
US11458158B2
(en)
|
2011-10-27 |
2022-10-04 |
Massachusetts Institute Of Technology |
Amino acid-, peptide- and polypeptide-lipids, isomers, compositions, and uses thereof
|
|
US11254936B2
(en)
|
2012-06-08 |
2022-02-22 |
Translate Bio, Inc. |
Nuclease resistant polynucleotides and uses thereof
|
|
US9439968B2
(en)
|
2012-08-13 |
2016-09-13 |
Massachusetts Institute Of Technology |
Amine-containing lipidoids and uses thereof
|
|
US9227917B2
(en)
|
2012-08-13 |
2016-01-05 |
Massachusetts Institute Of Technology |
Amine-containing lipidoids and uses thereof
|
|
US11510937B2
(en)
|
2013-03-14 |
2022-11-29 |
Translate Bio, Inc. |
CFTR MRNA compositions and related methods and uses
|
|
US11692189B2
(en)
|
2013-03-14 |
2023-07-04 |
Translate Bio, Inc. |
Methods for purification of messenger RNA
|
|
US9957499B2
(en)
|
2013-03-14 |
2018-05-01 |
Translate Bio, Inc. |
Methods for purification of messenger RNA
|
|
US10420791B2
(en)
|
2013-03-14 |
2019-09-24 |
Translate Bio, Inc. |
CFTR MRNA compositions and related methods and uses
|
|
US11820977B2
(en)
|
2013-03-14 |
2023-11-21 |
Translate Bio, Inc. |
Methods for purification of messenger RNA
|
|
US10876104B2
(en)
|
2013-03-14 |
2020-12-29 |
Translate Bio, Inc. |
Methods for purification of messenger RNA
|
|
US9713626B2
(en)
|
2013-03-14 |
2017-07-25 |
Rana Therapeutics, Inc. |
CFTR mRNA compositions and related methods and uses
|
|
US9315472B2
(en)
|
2013-05-01 |
2016-04-19 |
Massachusetts Institute Of Technology |
1,3,5-triazinane-2,4,6-trione derivatives and uses thereof
|
|
US10493031B2
(en)
|
2013-10-22 |
2019-12-03 |
Translate Bio, Inc. |
Lipid formulations for delivery of messenger RNA
|
|
US11224642B2
(en)
|
2013-10-22 |
2022-01-18 |
Translate Bio, Inc. |
MRNA therapy for argininosuccinate synthetase deficiency
|
|
US10959953B2
(en)
|
2013-10-22 |
2021-03-30 |
Translate Bio, Inc. |
Lipid formulations for delivery of messenger RNA
|
|
US9522176B2
(en)
|
2013-10-22 |
2016-12-20 |
Shire Human Genetic Therapies, Inc. |
MRNA therapy for phenylketonuria
|
|
US10208295B2
(en)
|
2013-10-22 |
2019-02-19 |
Translate Bio, Inc. |
MRNA therapy for phenylketonuria
|
|
US9629804B2
(en)
|
2013-10-22 |
2017-04-25 |
Shire Human Genetic Therapies, Inc. |
Lipid formulations for delivery of messenger RNA
|
|
US11890377B2
(en)
|
2013-10-22 |
2024-02-06 |
Translate Bio, Inc. |
Lipid formulations for delivery of messenger RNA
|
|
US11377642B2
(en)
|
2013-10-22 |
2022-07-05 |
Translate Bio, Inc. |
mRNA therapy for phenylketonuria
|
|
US10052284B2
(en)
|
2013-10-22 |
2018-08-21 |
Translate Bio, Inc. |
Lipid formulations for delivery of messenger RNA
|
|
US9850269B2
(en)
|
2014-04-25 |
2017-12-26 |
Translate Bio, Inc. |
Methods for purification of messenger RNA
|
|
US11884692B2
(en)
|
2014-04-25 |
2024-01-30 |
Translate Bio, Inc. |
Methods for purification of messenger RNA
|
|
US11059841B2
(en)
|
2014-04-25 |
2021-07-13 |
Translate Bio, Inc. |
Methods for purification of messenger RNA
|
|
US10155785B2
(en)
|
2014-04-25 |
2018-12-18 |
Translate Bio, Inc. |
Methods for purification of messenger RNA
|
|
US10493166B2
(en)
|
2014-05-30 |
2019-12-03 |
Translate Bio, Inc. |
Biodegradable lipids for delivery of nucleic acids
|
|
US10293057B2
(en)
|
2014-05-30 |
2019-05-21 |
Translate Bio, Inc. |
Biodegradable lipids for delivery of nucleic acids
|
|
US10286082B2
(en)
|
2014-05-30 |
2019-05-14 |
Translate Bio, Inc. |
Biodegradable lipids for delivery of nucleic acids
|
|
US10286083B2
(en)
|
2014-05-30 |
2019-05-14 |
Translate Bio, Inc. |
Biodegradable lipids for delivery of nucleic acids
|
|
US11433144B2
(en)
|
2014-05-30 |
2022-09-06 |
Translate Bio, Inc. |
Biodegradable lipids for delivery of nucleic acids
|
|
US10022455B2
(en)
|
2014-05-30 |
2018-07-17 |
Translate Bio, Inc. |
Biodegradable lipids for delivery of nucleic acids
|
|
US10912844B2
(en)
|
2014-05-30 |
2021-02-09 |
Translate Bio, Inc. |
Biodegradable lipids for delivery of nucleic acids
|
|
US10138213B2
(en)
|
2014-06-24 |
2018-11-27 |
Translate Bio, Inc. |
Stereochemically enriched compositions for delivery of nucleic acids
|
|
US11104652B2
(en)
|
2014-06-24 |
2021-08-31 |
Translate Bio, Inc. |
Stereochemically enriched compositions for delivery of nucleic acids
|
|
US9840479B2
(en)
|
2014-07-02 |
2017-12-12 |
Massachusetts Institute Of Technology |
Polyamine-fatty acid derived lipidoids and uses thereof
|
|
US10201618B2
(en)
|
2015-06-19 |
2019-02-12 |
Massachusetts Institute Of Technology |
Alkenyl substituted 2,5-piperazinediones, compositions, and uses thereof
|
|
US10695444B2
(en)
|
2015-06-19 |
2020-06-30 |
Massachusetts Institute Of Technology |
Alkenyl substituted 2,5-piperazinediones, compositions, and uses thereof
|
|
US11253605B2
(en)
|
2017-02-27 |
2022-02-22 |
Translate Bio, Inc. |
Codon-optimized CFTR MRNA
|
|
US11173190B2
(en)
|
2017-05-16 |
2021-11-16 |
Translate Bio, Inc. |
Treatment of cystic fibrosis by delivery of codon-optimized mRNA encoding CFTR
|
|
US11174500B2
(en)
|
2018-08-24 |
2021-11-16 |
Translate Bio, Inc. |
Methods for purification of messenger RNA
|
